Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hypertension Treatment

Increase Awareness, Compliance and Adherence!

    • Cardiology
    • Congress Reports
    • Nephrology
    • RX
  • 2 minute read

Although many hypertensive patients perform regular blood pressure measurements at home, a large proportion of these patients – 51% in the SWISSHYPE study published in 2011 [1] – are inadequately treated or have a low blood pressure. does not reach the target blood pressure values. This is due on the one hand to a lack of compliance and adherence on the part of many patients, but often also to a therapy that is not optimally developed.

A team from the Institute of Family Medicine in Zurich has shown that blood pressure can be reduced with the help of a very simple and inexpensive intervention, namely the ab-
The results of the blood pressure test are impressive (syst. -14 mmHg, diast. -8 mmHg) [2, 3]. This is achieved on the one hand by increasing compliance and adherence and on the other hand by improving awareness on the part of both patients and physicians.

In practice, 24-hour blood pressure measurement is a cost-effective and time-efficient measure for diagnosing patients with high blood pressure. NICE guidelines recommend that all patients with a blood pressure >140/90 mmHg should have one performed first [4]. If the mean blood pressure in this measurement is 135-150/85-95 mmHg, it is recommended that only lifestyle measures be taken initially in patients with no end-organ damage and no increased cardiovascular risk (this can be determined using the AGLA risk calculator, for example, www.agla.ch). If the patient already has end-organ damage and/or an increased cardiovascular risk or if the values are >150/95 mmHg, drug treatment should be started in addition to lifestyle measures [4]. At the SGIM congress in Basel, Thilo Burkhard, MD, Basel, recommended that younger patients (<55 years) should always be started primarily with an angiotensin receptor blocker (ARB) or an ACE inhibitor and older patients with a calcium antagonist(Fig. 1) [4].

If monotherapy is not sufficient, ARB resp. ACE inhibitors and calcium antagonists are combined and only in a third step, if necessary, a diuretic is added [4]. According to Dr. Burkhard, most patients require combination therapy to achieve target blood pressure levels on a sustained basis. He therefore recommended that in patients with grade 2 hypertension or in the presence of end-organ damage – in addition to the lifestyle measures that always belong! – to consider a combination therapy already initially. Especially in patients who still need to take additional medications, fixed-dose combination preparations contribute to a significant improvement in adherence.

Source: “Hypertension Treatment in Family Practice – Good, but can it be better?” Satellite Symposium of A. Menarini AG, SGIM Congress, May 29-31, 2013, Basel.

Literature:

  1. Brenner R, et al: Swiss Med Wkly 2011; 141: w13169.
  2. Steurer-Stey C, et al: Trials 2010; 11: 38.
  3. Rosemann T: Results of the CoCo study. Paper presented at the SGIM Annual Meeting 2013.
  4. NICE: CG127, 2011. http://guidance.nice.org.uk/CG127
Autoren
  • Dr. med. Sabina M. Ludin
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Adherence
  • Blood pressure
  • Compliance
  • Diagnostics
  • Hypertension
  • Target blood glucose levels
  • Therapy
Previous Article
  • Roundtable discussion

Use of conventional NSAIDs and coxibs in high-risk patients.

  • Cardiology
  • Gastroenterology and Hepatology
  • Hematology
  • Interviews
  • RX
View Post
Next Article
  • 9th Lucerne Trend Days Health

Swiss Healthcare – Quo vadis?

  • Congress Reports
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 12 min
  • Cancer prevention

Constant dripping – alcohol and cancer

    • CME continuing education
    • General Internal Medicine
    • Oncology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Steatotic liver disease

GLP-1RA in MASH – what’s new?

    • Congress Reports
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Chronic pruritus: “Tour d'horizon”

Focus on new anti-inflammatory therapeutic approaches

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Multiple sclerosis

Unexpected side effects when switching from natalizumab to a biosimilar

    • Education
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 3 min
  • Immunotherapy

Subcutaneously or intravenously?

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • Work-related asthma

When the job leads to exacerbations

    • Allergology and clinical immunology
    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 0 min
  • Inoperable NSCLC

Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 3 min
  • De-escalation strategies

De-escalation strategies – less is more

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Constant dripping – alcohol and cancer
  • 2
    Hurdles to pain treatment for autistic patients
  • 3
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 4
    Treatment of comorbidities in older people
  • 5
    New nomenclature for non-alcoholic fatty liver disease

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.